PAPER Bhattacharjee A, Purohit P, Roy PK

Neuroimaging-based drug discovery for amyloid clearance therapy in Alzheimer's disease using validated causation analysis.

Psychiatry Res Neuroimaging. 2024 Sep 5;345:111890. Epub 2024 Sep 5 PubMed.

PAPER Massaro Cenere M, Tiberi M, Paldino E, D'Addario SL, Federici M, Giacomet C, Cutuli D, Matteocci A, Cossa F, Zarrilli B, Casadei N, Ledonne A, Petrosini L, Berretta N, Fusco FR, Chiurchiù V, Mercuri NB

Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson's disease overexpressing human alpha synuclein.

NPJ Parkinsons Dis. 2024 Nov 5;10(1):213. PubMed.

PAPER Tremblay C, Adler CH, Shill HA, Driver-Dunckley E, Mehta S, Choudhury P, Belden C, Shprecher DR, Lee-Iannotti JK, Atri A, Serrano GE, Beach TG

Predicting Post-Mortem α-Synuclein Pathology by the Combined Presence of Probable REM sleep behavior disorder and Hyposmia.

Mov Disord Clin Pract. 2024 Nov 5; Epub 2024 Nov 5 PubMed.

PAPER Chelucci E, Scarfò G, Piccarducci R, Rizza A, Fusi J, Epifani F, Carpi S, Polini B, Betti L, Costa B, Taliani S, Cela V, Artini P, Daniele S, Martini C, Franzoni F

Sex Differences in Blood Accumulation of Neurodegenerative-Related Proteins and Antioxidant Responses to Regular Physical Exercise.

J Mol Neurosci. 2024 Nov 5;74(4):105. PubMed.

PAPER Longhena F, Boujelbene R, Brembati V, Sandre M, Bubacco L, Abbate S, Longhi G, Bellucci A

Correction: Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brain.

Nanoscale. 2024 Nov 4; Epub 2024 Nov 4 PubMed.

PAPER Malaty GR, Decourt B, Shill HA, Sabbagh MN

Biomarker Assessment in Parkinson's Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical Measures.

J Alzheimers Dis Rep. 2024;8(1):1361-1371. Epub 2024 Oct 25 PubMed.

PAPER Dues DJ, Ma Y, Nguyen AP, Offerman AV, Beddows I, Moore DJ

Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2.

Neurobiol Dis. 2023 Oct 28;:106338. Epub 2023 Oct 28 PubMed.

PAPER Yin S, Chi X, Wan F, Li Y, Zhou Q, Kou L, Sun Y, Wu J, Zou W, Wang Y, Jin Z, Huang J, Xiong N, Xia Y, Wang T

TREM2 signaling in Parkinson's disease: Regulation of microglial function and α-synuclein pathology.

Int Immunopharmacol. 2024 Oct 26;143(Pt 2):113446. Epub 2024 Oct 26 PubMed.

PAPER Burgaz S, Navarro E, Rodríguez-Carreiro S, Navarrete C, Garrido-Rodríguez M, Lastres-Becker I, Chocarro J, Lanciego JL, Muñoz E, Fernández-Ruiz J

Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.

Behav Brain Funct. 2024 Nov 1;20(1):28. PubMed.

PAPER Duan R, Shi L, Deng Y, Wu J, Wang S, Peng Q, Li Z, Xu Z, Wang F, Xue X, Gao Q

AVE0991 ameliorates dopaminergic neuronal damage in Parkinson's disease through HOTAIRM1/miR-223-3p/α-synuclein axis.

Sci Rep. 2024 Nov 1;14(1):26346. PubMed.

PAPER Brash-Arias D, García LI, Pérez-Estudillo CA, Rojas-Durán F, Aranda-Abreu GE, Herrera-Covarrubias D, Chi-Castañeda D

The Role of Astrocytes and Alpha-Synuclein in Parkinson's Disease: A Review.

NeuroSci. 2024 Mar;5(1):71-86. Epub 2024 Mar 8 PubMed.

PAPER Cohen-Adiv S, Amer-Sarsour F, Berdichevsky Y, Boxer E, Goldstein O, Gana-Weisz M, Tripathi U, Rike WA, Prag G, Gurevich T, Giladi N, Stern S, Orr-Urtreger A, Friedmann-Morvinski D, Ashkenazi A

TMEM16F regulates pathologic α-synuclein secretion and spread in cellular and mouse models of Parkinson's disease.

Aging Cell. 2024 Nov 2;:e14387. Epub 2024 Nov 2 PubMed.

PAPER Huettemann P, Mahadevan P, Lempart J, Tse E, Dehury B, Edwards BF, Southworth DR, Sahoo BR, Jakob U

Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils.

PLoS Biol. 2024 Oct;22(10):e3002650. Epub 2024 Oct 31 PubMed.

PAPER Mesias VS, Zhang J, Zhu H, Dai X, Li J, Huang J

Distinct Effects of SARS-CoV-2 Protein Segments on Structural Stability, Amyloidogenic Potential, and α-Synuclein Aggregation.

Chembiochem. 2024 Oct 31;:e202400598. Epub 2024 Oct 31 PubMed.

PAPER de Oliveira FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, de Andrade Matas SL, Bertolucci PH, da Graça Naffah-Mazzacoratti M

Anthropometric and Demographic Features Affect the Interpretation of Cerebrospinal Fluid Biomarkers in Patients with Different Dementia Syndromes and Cognitively Healthy Adults.

Neuromolecular Med. 2024 Nov 1;26(1):43. PubMed.